showed that miR-16 decreases the expression of the pro-oncogenic HuR protein in breast cancer by inhibiting the translatability of its mRNA via direct interaction within the 3’UTR of HuR transcript (25). This evidence concerns the gene ELAVL1 and breast carcinoma.